| 產品編號 | V22720 |
| 英文名稱 | Influenza A Nucleoprotein |
| 中文名稱 | 甲型流感病毒核蛋白單克隆抗體 |
| 別 名 | Common flu NP; Influenza A virus NP; NP; Nucleocapsid protein; Nucleoprotein; Protein N; Seasonal Influenza A (H1N1) Nucleocapsid Protein |
| 理論分子量 | 56kDa |
| 性 狀 | Lyophilized or Liquid |
| 緩 沖 液 | 0.01M PBS(pH7.4) |
| 保存條件 | Shipped at 2-8℃. |
| 產品介紹 |
Influenza A virus is a major public health threat. Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. HA interacts with cell surface proteins containing oligosaccharides with terminal sialyl residues. Virus isolated from a human infected with the H5N1 strain in 1997 could bind to oligosaccharides from human as well as avian sources, indicating its species jumping ability.
Influenza A Virus [A/California/04/2009(H1N1)] A型流感病毒H5N1-M2型流感病毒與很多流感病毒型同源,其同源性很高：H7N7 H9N2 H13N6 H16N3 H1N1 N2N1 H3N2 H2N2 等等并仍在不斷的變異。 |
| 1、抗體溶解方法 | |
| 2、抗體修復方式 | |
| 3、常用試劑的配制 | |
| 4、免疫組化操作步驟 | |
| 5、免疫組化問題解答 | |
| 6、Western Blotting 操作步驟 | |
| 7、Western Blotting 問題解答 | |
| 8、關于肽鏈的設計 | |
| 9、多肽的溶解與保存 | |
| 10、酶標抗體效價測定程序 | |
